Skip to content

MapLight Therapeutics, Inc. MPLT Balance Sheet Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$55.71M+19.2%$46.73M-27.2%$64.15M
$254.41M-1.5%$258.37M+58.5%$163.02M
$327.23M+0.8%$324.67M+32.4%$245.31M
$968K-11.6%$1.1M+27.5%$859K
$418.79M-12.7%$479.51M+86.4%$257.22M
$3.19M-3.1%$3.29M+34.5%$2.45M-$1.05M-155%
$14.28M-12.0%$16.23M-12.6%$18.56M
$18.95M-10.3%$21.14M-10.8%$23.71M
$5K0.0%$5K$0
-$421.19M-16.8%-$360.52M-28.3%-$280.97M
$399.83M-12.8%$458.37M+267%-$274.18M-11.9%-$245.06M-13.5%-$215.83M-11.5%
$418.79M-12.7%$479.51M+86.4%$257.22M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are MapLight Therapeutics, Inc. 's total assets?
MapLight Therapeutics, Inc. (MPLT) holds $418.8M in total assets.
How much debt does MapLight Therapeutics, Inc. have?
MapLight Therapeutics, Inc. carries $5.6M in total debt against $399.8M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does MapLight Therapeutics, Inc. have?
MapLight Therapeutics, Inc. holds $55.7M in cash and equivalents.
Can MapLight Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 22.91 — current assets exceed current liabilities.
Where does MapLight Therapeutics, Inc. 's balance sheet data come from?
Every line is extracted from MapLight Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.